INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2021

A commentary notes clinical evidence that an NAD+ booster increases muscle insulin sensitivity in postmenopausal prediabetic women.

This commentary highlights findings from Yoshino et al. (2021) regarding NAD+ boosters. The authors note that clinical evidence demonstrates an NAD+ booster increases muscle insulin sensitivity in postmenopausal prediabetic women. This validates the therapeutic potential of NAD+ boosters in humans for addressing metabolic disorders associated with aging and obesity.

Study type
Commentary on clinical evidence
Who was studied
Postmenopausal prediabetic women
What was measured
Muscle insulin sensitivity

THE PAPER

The therapeutic promises of NAD+ boosters.

Montllor-Albalate C, Song Z, Chen D. Cell Metab, 2021.

PubMed 34233170 ↗DOI 10.1016/j.cmet.2021.06.008 ↗

Diabetes & blood sugarNutrients & adequacyWeight & appetiteHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.